Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States

Purpose: Real-world data comparing long-term performance of interleukin (IL)-23 and IL-17 inhibitors in psoriasis are limited. This study compared treatment persistence and remission among patients initiating guselkumab versus IL-17 inhibitors.Methods: Adults with psoriasis initiating guselkumab, se...

Full description

Bibliographic Details

Published in:	Journal of Dermatological Treatment
Main Authors:	Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, Lilian Diaz, Patrick Lefebvre, Steven R. Feldman
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	Psoriasis biologics guselkumab treatment discontinuation persistence remission
Online Access:	https://www.tandfonline.com/doi/10.1080/09546634.2024.2349658